Physcient

Executive Summary

Physcient, headquartered in Durham, NC, is a pre-clinical medical device company pioneering Differential Dissection™ technology, which selectively disrupts soft connective tissues while sparing critical structures like blood vessels, organ capsules, and nerve sheaths. Founded in 2008, the company addresses a fundamental challenge in surgery: safe and efficient tissue separation. Its platform has the potential to reduce operative time, minimize collateral damage, and improve patient outcomes across multiple surgical specialties. With over a decade of development, Physcient is positioned to enter formal preclinical studies and seek FDA clearance for its initial indications. The technology's unique mechanism could establish a new standard in surgical dissection, offering significant advantages over existing energy-based or mechanical tools.

Upcoming Catalysts (preview)

• Q2 2027Completion of preclinical safety and efficacy studies60% success
• Q4 2027First FDA IDE submission for a clinical trial50% success
• Q3 2027Strategic partnership or licensing deal with a larger surgical device company40% success